Follow
Rachel Eguia
Rachel Eguia
Verified email at fredhutch.org
Title
Cited by
Cited by
Year
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
AJ Greaney, TN Starr, P Gilchuk, SJ Zost, E Binshtein, AN Loes, SK Hilton, ...
Cell host & microbe 29 (1), 44-57. e9, 2021
7872021
Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays
KHD Crawford, R Eguia, AS Dingens, AN Loes, KD Malone, CR Wolf, ...
Viruses 12 (5), 513, 2020
5092020
Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection
KHD Crawford, AS Dingens, R Eguia, CR Wolf, N Wilcox, JK Logue, ...
The Journal of infectious diseases 223 (2), 197-205, 2021
2362021
A human coronavirus evolves antigenically to escape antibody immunity
RT Eguia, KHD Crawford, T Stevens-Ayers, L Kelnhofer-Millevolte, ...
PLoS pathogens 17 (4), e1009453, 2021
1492021
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
JM Lee, R Eguia, SJ Zost, S Choudhary, PC Wilson, T Bedford, ...
Elife 8, e49324, 2019
662019
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak
AS Dingens, KHD Crawford, A Adler, SL Steele, K Lacombe, R Eguia, ...
Nature communications 11 (1), 1-6, 2020
602020
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
AJ Greaney, TN Starr, RT Eguia, AN Loes, K Khan, F Karim, S Cele, ...
PLoS pathogens 18 (2), e1010248, 2022
322022
Comprehensive mapping of adaptation of the avian influenza polymerase protein PB2 to humans
YQS Soh, LH Moncla, R Eguia, T Bedford, JD Bloom
Elife 8, e45079, 2019
302019
Comprehensive profiling of mutations to influenza virus PB2 that confer resistance to the cap-binding inhibitor pimodivir
YQS Soh, KD Malone, RT Eguia, JD Bloom
Viruses 13 (7), 1196, 2021
42021
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
AJ Greaney, RT Eguia, TN Starr, K Khan, N Franko, JK Logue, SM Lord, ...
bioRxiv, 2022
32022
Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
AG Farrell, B Dadonaite, AJ Greaney, R Eguia, AN Loes, NM Franko, ...
Viruses 14 (9), 2061, 2022
2022
1 2 3 4 5 6 7 8 9Lead contact* Correspondence: https://doi. org
MA Tortorici, AC Walls, A Joshi, YJ Park, RT Eguia, MC Miranda, E Kepl, ...
CELL 185 (13), 2279-+, 2022
2022
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes (preprint)
A Greaney, R Eguia, T Starr, K Khan, N Franko, J Logue, S Lord, ...
2022
The system can't perform the operation now. Try again later.
Articles 1–13